2018 annual financial data
Vistagen Therapeutics 2018 Operating margin
Vistagen Therapeutics 2018 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -14,199,600 USD and net income was -14,345,900 USD.
Operating cash flow was -9,058,300 USD.
Get free Vistagen Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -14,199,600 USD
- Net income
- -14,345,900 USD
- Operating cash flow
- -9,058,300 USD